The FDA introduced Elsa, an artificial intelligence (AI) tool intended to enhance efficiency in clinical reviews and ...

Pentacam and corneal topography were more sensitive to tear film abnormalities when measuring the curvature of the cornea in ...

Darolutamide (Nubeqa) is granted FDA approval for metastatic castration-sensitive prostate cancer, enhancing survival and ...

US claims data show patients with generalized pustular psoriasis (GPP) face up to a 4-fold higher mortality risk compared ...

Men’s Health Month 2025 encourages men to adopt preventive care and healthy lifestyle habits to improve overall health ...

"Political directives should not prevent individuals from seeking safe and effective care that they desire and deserve," ...

According to Merrill H. Stewart, MD, Ochsner Health, the test can more accurately identify high-risk patients while helping others avoid unnecessary invasive procedures.

C, features insights on how unaddressed chronic allergy symptoms contribute to mental health burdens and the critical role of early immunoglobulin E trigger identification in managing both physical ...

Relacorilant combined with nab-paclitaxel (Abraxane) significantly improved progression-free and overall survival in patients with platinum-resistant ovarian cancer in the phase 3 ROSELLA trial, ...

A circulating tumor DNA (ctDNA) blood test demonstrated high sensitivity and specificity for colorectal cancer (CRC) detection in a large average-risk population, study finds.

Developments in artificial intelligence (AI) can help clinicians to diagnose thoracic conditions that may be miss on first glance.

This contributor column discusses a recent study that shows the 340B Program’s explosive growth is overwhelmingly due to ...